RxDoctor Payments Data

Marwan Shuayto, MD

Neurology · Port Huron, MINPI 1841383924

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (54.2%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 58 manufacturers reported payments, led by Boston Scientific at 28.4% of the total. Reporting peaked in 2021 at $8,491 and has fallen 65.1% since, to $2,966 in 2025.

$23,555in general payments, 2019–2025

Across 773 payments — averaging $30.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$7K
  • Abbott$3K
  • Nalu Medical, Inc.$2K
  • AbbVie$2K
  • Livanova USA, Inc.$2K
  • Novartis$2K
  • plus $7K from 52 others
$153,861in research payments, 2019–2025

Across 62 payments — averaging $2481.63 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Nalu Medical, Inc.$154K

What the payments were for

  • Consulting fees$6,77529%
  • Speaking & faculty fees$520%
  • Travel & lodging$3,83716%
  • Food & beverage$12,77454%
  • Education$1170%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Boston Scientific21$6,693
Abbott62$2,621
Nalu Medical, Inc.16$2,007
AbbVie(2 entities)113$1,744
Livanova USA, Inc.4$1,721
Novartis123$1,636
Amgen(2 entities)62$839
Biogen35$556
EMD Serono, Inc.36$552
Teva Pharmaceuticals USA, Inc.30$477
Bristol Myers Squibb31$434
Johnson & Johnson(2 entities)16$311
Genentech USA, Inc.17$302
Eisai Inc.14$292
UCB, Inc.18$265
Sunovion Pharmaceuticals Inc.16$239
Nevro Corp.11$232
TG Therapeutics, Inc.9$208
Pfizer12$178
Lundbeck LLC9$173
Grifols USA, LLC7$145
Sumitomo Pharma America, Inc.8$130
CSL Behring5$110
Argenx US, Inc.5$105
Avanir Pharmaceuticals, Inc.7$98
Medtronic(2 entities)5$96
Supernus Pharmaceuticals, Inc.6$96
Lilly USA, LLC5$89
E.r. Squibb & Sons, L.L.C.6$87
AstraZeneca5$81
Catalyst Pharmaceuticals, Inc.3$80
Biohaven Pharmaceuticals, Inc.6$78
Sanofi3$68
Vanda Pharmaceuticals Inc.3$54
Dentsply Sirona Inc1$54
Acorda Therapeutics, Inc3$52
Neurelis, Inc.4$48
Otsuka America Pharmaceutical, Inc.2$47
Vertos Medical, Inc.2$41
Amneal Pharmaceuticals LLC2$38
Aprecia Pharmaceuticals, LLC3$37
Acadia Pharmaceuticals Inc2$37
GE HealthCare2$36
Otsuka Pharmaceutical Development & Commercialization, Inc.2$34
Xeris Pharmaceuticals, Inc.2$33
Piramal Critical Care2$33
Neurocrine Biosciences, Inc.2$32
SPR Therapeutics, Inc2$29
Biohaven Pharmaceutical Holding Company Ltd.1$28
Kyowa Kirin, Inc.2$27
ANI Pharmaceuticals, Inc.1$25
Aucta Pharmaceuticals, Inc.2$24
Scilex Pharmaceuticals Inc.1$22
Axsome Therapeutics, Inc.1$21
Adamas Pharmaceuticals, Inc.1$21
SK Life Science, Inc.1$20
Saluda Medical Americas, Inc.1$13
Si-bone, Inc.2$7

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$23,555 in reported general payments places this provider in the 85th percentile of 652 neurology providers in Michigan.

See all neurology providers in Michigan

Medicare billing

Part B allowed, 2024
$643,134
Medicare patients
657
Services billed
33,650

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen94$1,192
Pregabalin18$683
Dextrose In WaterDextrose 10 % In Water43$405
Gabapentin37$393
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen26$376
Topiramate20$353
Naproxen47$298
Cephalexin43$189
Baclofen22$189
Oxycodone Hcl13$143
Tramadol Hcl17$118
Primidone13$105
Meloxicam13$13
Diazepam13$12
Lorazepam11$5

Paid to pharmacies, not to this prescriber.

Other neurology in Port Huron

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →